Skip to main content
Clinical Trials/NCT03123237
NCT03123237UnknownPhase 4

Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.

Assiut University1 site in 1 country45 target enrollmentStarted: July 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Enrollment
45
Locations
1
Primary Endpoint
Renal Counts

Study Overview

Brief Summary

the investigators explore the possible role of DMSA to detect renal affection in diabetic &/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control & diabetic &/or hypertensive patients.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • • Patients with diabetes (type2), weather controlled or not.
  • Patients with essential hypertension.
  • Patients with diabetes & hypertension.
  • Within normal renal function (urea & creatinine).
  • Control cases may be normal individuals (apparently healthy) like donors for renal transplant.

Exclusion Criteria

  • • Patients with abnormal renal function.
  • Patients with diseases known to affect kidney function rather diabetes & hypertension e.g. SLE, heart failure or liver cell failure.

Outcomes

Primary Outcomes

Renal Counts

Time Frame: 2-4 hours

Quantitative Tc99m DMSA renal scan using SPECT technique will be used to measure renal function.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hebat Allah Ahmed Askar

Principle investigator

Assiut University

Study Sites (1)

Loading locations...

Similar Trials

Quantitative Renal Uptake Using TC99m DMSA... | Clinical Trial